408 related articles for article (PubMed ID: 7587059)
1. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.
Hurlin PJ; Ayer DE; Grandori C; Eisenman RN
Cold Spring Harb Symp Quant Biol; 1994; 59():109-16. PubMed ID: 7587059
[TBL] [Abstract][Full Text] [Related]
2. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
[TBL] [Abstract][Full Text] [Related]
3. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
Larsson LG; Bahram F; Burkhardt H; Lüscher B
Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
[TBL] [Abstract][Full Text] [Related]
5. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Ayer DE; Eisenman RN
Genes Dev; 1993 Nov; 7(11):2110-9. PubMed ID: 8224841
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
7. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
Hurlin PJ; Quéva C; Eisenman RN
Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
Lahoz EG; Xu L; Schreiber-Agus N; DePinho RA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5503-7. PubMed ID: 8202517
[TBL] [Abstract][Full Text] [Related]
9. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
Ayer DE; Kretzner L; Eisenman RN
Cell; 1993 Jan; 72(2):211-22. PubMed ID: 8425218
[TBL] [Abstract][Full Text] [Related]
10. Dynamic in vivo interactions among Myc network members.
Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
[TBL] [Abstract][Full Text] [Related]
11. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death.
Amati B; Land H
Curr Opin Genet Dev; 1994 Feb; 4(1):102-8. PubMed ID: 8193530
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis.
Hurlin PJ; Foley KP; Ayer DE; Eisenman RN; Hanahan D; Arbeit JM
Oncogene; 1995 Dec; 11(12):2487-501. PubMed ID: 8545105
[TBL] [Abstract][Full Text] [Related]
14. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
James L; Eisenman RN
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
[TBL] [Abstract][Full Text] [Related]
15. The Myc/Max/Mad network and the transcriptional control of cell behavior.
Grandori C; Cowley SM; James LP; Eisenman RN
Annu Rev Cell Dev Biol; 2000; 16():653-99. PubMed ID: 11031250
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
[TBL] [Abstract][Full Text] [Related]
17. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
18. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
Grinberg AV; Hu CD; Kerppola TK
Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
[TBL] [Abstract][Full Text] [Related]
19. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
20. Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network.
Foley KP; Eisenman RN
Biochim Biophys Acta; 1999 May; 1423(3):M37-47. PubMed ID: 10382539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
